Page last updated: 2024-10-16

carbon monoxide and Neuromuscular Junction Diseases

carbon monoxide has been researched along with Neuromuscular Junction Diseases in 1 studies

Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.

Neuromuscular Junction Diseases: Conditions characterized by impaired transmission of impulses at the NEUROMUSCULAR JUNCTION. This may result from disorders that affect receptor function, pre- or postsynaptic membrane function, or ACETYLCHOLINESTERASE activity. The majority of diseases in this category are associated with autoimmune, toxic, or inherited conditions.

Research Excerpts

ExcerptRelevanceReference
"Carbon monoxide (CO) has gained recent attention as therapy to reduce the deleterious effects of CPB."1.36Impairment of diaphragm muscle force and neuromuscular transmission after normothermic cardiopulmonary bypass: effect of low-dose inhaled CO. ( Atchison, FW; Ereth, MH; Ermilov, LG; Mantilla, CB; Pulido, JN; Sieck, GC; Zhan, WZ, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ermilov, LG1
Pulido, JN1
Atchison, FW1
Zhan, WZ1
Ereth, MH1
Sieck, GC1
Mantilla, CB1

Other Studies

1 other study available for carbon monoxide and Neuromuscular Junction Diseases

ArticleYear
Impairment of diaphragm muscle force and neuromuscular transmission after normothermic cardiopulmonary bypass: effect of low-dose inhaled CO.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2010, Volume: 298, Issue:3

    Topics: Administration, Inhalation; Animals; Antimetabolites; Body Temperature; Carbon Dioxide; Carbon Monox

2010